162 related articles for article (PubMed ID: 29112958)
1. Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
Boyd MA; Mocroft A; Ryom L; Monforte AD; Sabin C; El-Sadr WM; Hatleberg CI; De Wit S; Weber R; Fontas E; Phillips A; Bonnet F; Reiss P; Lundgren J; Law M
PLoS Med; 2017 Nov; 14(11):e1002424. PubMed ID: 29112958
[TBL] [Abstract][Full Text] [Related]
2. Serious clinical events in HIV-positive persons with chronic kidney disease.
Ryom L; Lundgren JD; Law M; Kirk O; El-Sadr W; Bonnet F; Weber R; Fontas E; Monforte AD; Phillips A; Reiss P; de Wit S; Hatleberg CI; Sabin C; Mocroft A;
AIDS; 2019 Nov; 33(14):2173-2188. PubMed ID: 31385862
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; ; ; ; ;
PLoS Med; 2015 Mar; 12(3):e1001809. PubMed ID: 25826420
[TBL] [Abstract][Full Text] [Related]
4. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.
Mills AM; Schulman KL; Fusco JS; Brunet L; Hsu R; Beyer A; Prajapati G; Mounzer K; Fusco GP
HIV Med; 2020 May; 21(5):299-308. PubMed ID: 31985887
[TBL] [Abstract][Full Text] [Related]
6. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
[TBL] [Abstract][Full Text] [Related]
7. Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific.
Han WM; Bijker R; Chandrasekaran E; Pujari S; Ng OT; Ly PS; Lee MP; Van Nguyen K; Chan YJ; Do CD; Choi JY; Chaiwarith R; Merati TP; Kiertiburanakul S; Azwa I; Khusuwan S; Zhang F; Gani YM; Tanuma J; Sangle S; Ditangco R; Yunihastuti E; Ross J; Avihingsanon A;
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):489-497. PubMed ID: 33136750
[TBL] [Abstract][Full Text] [Related]
8. Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.
Ganesan A; Krantz EM; Huppler Hullsiek K; Riddle MS; Weintrob AC; Lalani T; Okulicz JF; Landrum M; Agan B; Whitman TJ; Ross MJ; Crum-Cianflone NF;
HIV Med; 2013 Feb; 14(2):65-76. PubMed ID: 22808988
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis.
Kochi M; Kohagura K; Shiohira Y; Iseki K; Ohya Y
J Cardiol; 2018 Mar; 71(3):277-283. PubMed ID: 28969969
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
Peters L; Grint D; Lundgren JD; Rockstroh JK; Soriano V; Reiss P; Grzeszczuk A; Sambatakou H; Mocroft A; Kirk O;
AIDS; 2012 Sep; 26(15):1917-26. PubMed ID: 22781222
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of atheromatous and non-atheromatous cardiovascular disease by age in chronic kidney disease.
Villain C; Metzger M; Combe C; Fouque D; Frimat L; Jacquelinet C; Laville M; Briançon S; Klein J; Schanstra JP; Robinson BM; Mansencal N; Stengel B; Massy ZA
Nephrol Dial Transplant; 2020 May; 35(5):827-836. PubMed ID: 30169874
[TBL] [Abstract][Full Text] [Related]
13. Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data.
Schlackow I; Simons C; Oke J; Feakins B; O'Callaghan CA; Hobbs FDR; Lasserson D; Stevens RJ; Perera R; Mihaylova B
PLoS Med; 2020 Dec; 17(12):e1003478. PubMed ID: 33326459
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
[TBL] [Abstract][Full Text] [Related]
15. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
Beddhu S; Rocco MV; Toto R; Craven TE; Greene T; Bhatt U; Cheung AK; Cohen D; Freedman BI; Hawfield AT; Killeen AA; Kimmel PL; Lash J; Papademetriou V; Rahman M; Rastogi A; Servilla K; Townsend RR; Wall B; Whelton PK;
Ann Intern Med; 2017 Sep; 167(6):375-383. PubMed ID: 28869987
[TBL] [Abstract][Full Text] [Related]
16. Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.
Kamara DA; Ryom L; Ross M; Kirk O; Reiss P; Morlat P; Moranne O; Fux CA; Mocroft A; Sabin C; Lundgren JD; Smith CJ;
BMC Nephrol; 2014 Mar; 15():51. PubMed ID: 24666792
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular events and death in Japanese patients with chronic kidney disease.
Tanaka K; Watanabe T; Takeuchi A; Ohashi Y; Nitta K; Akizawa T; Matsuo S; Imai E; Makino H; Hishida A;
Kidney Int; 2017 Jan; 91(1):227-234. PubMed ID: 27884399
[TBL] [Abstract][Full Text] [Related]
18. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
Ryom L; Mocroft A; Kirk O; Worm SW; Kamara DA; Reiss P; Ross M; Fux CA; Morlat P; Moranne O; Smith C; Lundgren JD;
J Infect Dis; 2013 May; 207(9):1359-69. PubMed ID: 23382571
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of chronic kidney disease in patients with coronary heart disease: role of estimating equations.
Zhang QL; Brenner H; Koenig W; Rothenbacher D
Atherosclerosis; 2010 Jul; 211(1):342-7. PubMed ID: 20347445
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate.
Dietrich LG; Barceló C; Thorball CW; Ryom L; Burkhalter F; Hasse B; Furrer H; Weisser M; Steffen A; Bernasconi E; Cavassini M; de Seigneux S; Csajka C; Fellay J; Ledergerber B; Tarr PE
Clin Infect Dis; 2020 Feb; 70(5):890-897. PubMed ID: 30953057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
